Clinical Trials

Kidney Cancer (Renal Cancer)

At Lehigh Valley Health Network, we are committed to providing our patients and community with the best possible care and treatments. Our research scientists are integrated with our clinical departments for a comprehensive, collaborative approach to research. Have a question about clinical trials? Contact the Network Office of Research and Innovation at 610-402-9543.

Showing 7 of 7 Clinical Trials Related to Kidney Cancer (Renal Cancer)

NRG-GU012 Renal Cancer

NRG-GU012, “Randomized Phase II Stereotactic Ablative Radiation Therapy (SABR) For Metastatic Unresected Renal Cell Carcinoma (RCC) Receiving Immunotherapy (SAMURAI)”

...
Doctor(s) Running This Study
Maged F. Khalil, MD

MSK 21-467 Renal Cancer

A Phase 3, Randomized, Controlled, Multicenter, Open-label Study to Compare Tivozanib in Combination with Nivolumab to Tivozanib Monotherapy in Subjects with Renal Cell Carcinoma Who Have Progressed Following One or

...
Doctor(s) Running This Study
Suresh G. Nair, MD

A031704 Renal Cell Cancer

PD-INHIBITOR (NIVOLUMAB) AND IPILIMUMAB FOLLOWED BY NIVOLUMAB VS. VEGF TKI CABOZANTINIB WITH NIVOLUMAB: A PHASE III TRIAL IN METASTATIC UNTREATED RENAL CELL CANCER [PDIGREE]

...
Doctor(s) Running This Study
Maged F. Khalil, MD

Merck 6482-011 Renal Cancer

An Open-label, Randomized, Phase 3 Study of MK-6482 in Combination with Lenvatinib (MK-7902) vs Cabozantinib for Second-line or Third-line Treatment in Participants with Advanced Renal Cell Carcinoma Who Have Progressed

...
Doctor(s) Running This Study
Suresh G. Nair, MD

EA8143

Phase 3 RandOmized Study Comparing PERioperative Nivolumab vs. Observation in Patients with Localized Renal Cell Carcinoma Undergoing Nephrectomy (PROSPER RCC)

...
Doctor(s) Running This Study
Maged F. Khalil, MD

A031702

A Phase II Study of Ipilimumab, Cabozantinib, and Nivolumab in Rare Genitourinary Cancers (ICONIC)

...
Doctor(s) Running This Study
Maged F. Khalil, MD